down arrow

Lincoln Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
552.90
14.65 (2.72%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 13.98 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidated - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
20.03
20.03
20.03
20.03
20.00
20.00
Share Warrants & Outstandings
Total Reserve
572.81
482.44
412.85
346.36
293.09
249.34
Shareholder's Funds
592.84
502.47
432.88
366.39
313.09
269.34
Minority Interest
0.00
0.00
0.00
0.00
0.38
0.36
Long-Term Borrowings
0.00
0.00
0.00
0.14
1.24
3.52
Secured Loans
0.00
0.00
0.00
0.14
1.24
3.52
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
11.46
7.94
6.45
5.69
5.43
5.58
Other Long Term Liabilities
3.6245
4.7212
4.5391
4.2916
4.0524
3.675
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.10
0.14
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
15.18
12.80
10.99
10.13
10.33
10.95
Current Liabilities
Trade Payables
72.44
50.87
71.67
57.07
51.24
44.01
Other Current Liabilities
15.25
15.39
14.12
16.22
10.06
11.23
Short Term Borrowings
1.07
2.00
2.04
0.38
3.83
30.09
Short Term Provisions
3.52
3.89
2.66
2.18
0.44
0.00
Total Current Liabilities
92.28
72.15
90.49
75.84
65.58
85.34
Total Liabilities
700.29
587.42
534.36
452.36
389.39
365.98
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
236.33
197.16
170.75
141.58
146.38
138.11
Less: Accumulated Depreciation
57.21
46.86
39.12
31.22
23.95
17.21
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
179.12
150.30
131.63
110.36
122.42
120.91
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
3.48
6.71
16.05
1.69
0.04
2.10
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.09
0.09
Long Term Loans & Advances
70.62
62.49
31.83
30.83
18.51
18.52
Other Non Current Assets
0.12
0.47
1.75
0.45
0.03
9.56
Total Non-Current Assets
253.55
220.21
181.51
143.61
141.39
141.94
Current Assets Loans & Advances
Current Investments
138.92
91.33
96.81
80.66
34.22
18.07
Inventories
77.17
70.03
72.74
46.61
47.40
36.23
Sundry Debtors
161.77
136.33
115.94
113.35
101.34
122.47
Cash and Bank
13.83
34.32
18.80
13.84
14.58
7.58
Other Current Assets
1.62
1.96
0.53
1.22
1.09
1.81
Short Term Loans and Advances
53.43
33.25
48.03
53.06
49.38
37.89
Total Current Assets
446.74
367.21
352.85
308.75
248.00
224.04
Net Current Assets (Including Current Investments)
354.46
295.07
262.36
232.91
182.41
138.71
Total Current Assets Excluding Current Investments
307.82
275.89
256.04
228.09
213.78
205.97
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
700.29
587.42
534.36
452.36
389.39
365.98
Contingent Liabilities
0.23
0.23
0.23
2.30
2.19
2.19
Total Debt
1.07
2.00
2.04
0.52
4.68
31.79
Book Value per share (adjusted)
295.98
250.86
216.12
182.92
156.54
134.67
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2024 is -46.50% vs -1.96% in Mar 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2024 is -23.31% vs 3.96% in Mar 2023

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2024 is 16.30% vs 6.32% in Mar 2023

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2024 is 21.66% vs 4.07% in Mar 2023

Compare Balance Sheet Results of Lincoln Pharma.
Markets Mojo
Figures in Rs cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
20.03
40.06
-20.03
-50.00%
Share Warrants & Outstandings
Total Reserve
572.81
9,299.78
-8,726.97
-93.84%
Shareholder's Funds
592.84
9,363.09
-8,770.25
-93.67%
Minority Interest
0.00
212.70
-212.70
-100.00%
Long-Term Borrowings
0.00
24.87
-24.87
-100.00%
Secured Loans
0.00
24.87
-24.87
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
11.46
8.67
2.79
32.18%
Other Long Term Liabilities
3.62
30.68
-27.06
-88.20%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.10
123.12
-123.02
-99.92%
Total Non-Current Liabilities
15.18
187.34
-172.16
-91.90%
Current Liabilities
Trade Payables
72.44
1,102.99
-1,030.55
-93.43%
Other Current Liabilities
15.25
456.26
-441.01
-96.66%
Short Term Borrowings
1.07
171.17
-170.10
-99.37%
Short Term Provisions
3.52
389.31
-385.79
-99.10%
Total Current Liabilities
92.28
2,119.73
-2,027.45
-95.65%
Total Liabilities
700.29
11,882.86
-11,182.57
-94.11%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
236.33
5,775.71
-5,539.38
-95.91%
Less: Accumulated Depreciation
57.21
1,354.82
-1,297.61
-95.78%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
179.12
4,420.89
-4,241.77
-95.95%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
3.48
207.09
-203.61
-98.32%
Intangible assets under development
0.00
74.70
-74.70
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
315.12
-315.12
-100.00%
Long Term Loans & Advances
70.62
163.97
-93.35
-56.93%
Other Non Current Assets
0.12
13.79
-13.67
-99.13%
Total Non-Current Assets
253.55
5,314.63
-5,061.08
-95.23%
Current Assets Loans & Advances
Current Investments
138.92
2,258.11
-2,119.19
-93.85%
Inventories
77.17
1,553.46
-1,476.29
-95.03%
Sundry Debtors
161.77
848.28
-686.51
-80.93%
Cash and Bank
13.83
1,197.97
-1,184.14
-98.85%
Other Current Assets
1.62
106.80
-105.18
-98.48%
Short Term Loans and Advances
53.43
610.77
-557.34
-91.25%
Total Current Assets
446.74
6,568.23
-6,121.49
-93.20%
Net Current Assets (Including Current Investments)
354.46
4,448.50
-4,094.04
-92.03%
Total Current Assets Excluding Current Investments
307.82
4,310.11
-4,002.29
-92.86%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
700.29
11,882.86
-11,182.57
-94.11%
Contingent Liabilities
0.23
116.23
-116.00
-99.80%
Total Debt
1.07
196.04
-194.97
-99.45%
Book Value per share (adjusted)
295.98
233.73
62.25
26.63%
Annual - Borrowings
Borrowings 1.07 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -46.50% vs -1.96% in Mar 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 3.62 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -23.31% vs 3.96% in Mar 2023

Annual - Fixed Assets
Fixed Assets 182.60 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 16.30% vs 6.32% in Mar 2023

Annual - Investments
Investments 0.00 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 446.74 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 21.66% vs 4.07% in Mar 2023